NO965236L - Aktiv substans-bærer for kontrollert frigjöring av aktiv substans i magetarmkanalen med utsatt passering gjennom pylorus - Google Patents

Aktiv substans-bærer for kontrollert frigjöring av aktiv substans i magetarmkanalen med utsatt passering gjennom pylorus

Info

Publication number
NO965236L
NO965236L NO965236A NO965236A NO965236L NO 965236 L NO965236 L NO 965236L NO 965236 A NO965236 A NO 965236A NO 965236 A NO965236 A NO 965236A NO 965236 L NO965236 L NO 965236L
Authority
NO
Norway
Prior art keywords
active substance
pylorus
controlled release
gastrointestinal tract
carrier
Prior art date
Application number
NO965236A
Other languages
English (en)
Norwegian (no)
Other versions
NO965236D0 (no
Inventor
Bodo Asmussen
Karsten Cremer
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of NO965236D0 publication Critical patent/NO965236D0/no
Publication of NO965236L publication Critical patent/NO965236L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
NO965236A 1994-06-07 1996-12-06 Aktiv substans-bærer for kontrollert frigjöring av aktiv substans i magetarmkanalen med utsatt passering gjennom pylorus NO965236L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4419818A DE4419818C2 (de) 1994-06-07 1994-06-07 Wirkstoffträger zur kontrollierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt mit verzögerter Pyloruspassage und Verfahren zur Herstellung desselben
PCT/EP1995/002121 WO1995033449A1 (fr) 1994-06-07 1995-06-03 Excipient destine a la liberation controlee de principes actifs dans le tractus gastro-intestinal avec passage retarde dans le pylore

Publications (2)

Publication Number Publication Date
NO965236D0 NO965236D0 (no) 1996-12-06
NO965236L true NO965236L (no) 1996-12-06

Family

ID=6519958

Family Applications (1)

Application Number Title Priority Date Filing Date
NO965236A NO965236L (no) 1994-06-07 1996-12-06 Aktiv substans-bærer for kontrollert frigjöring av aktiv substans i magetarmkanalen med utsatt passering gjennom pylorus

Country Status (21)

Country Link
EP (1) EP0765158B1 (fr)
JP (1) JP3801200B2 (fr)
KR (1) KR100499898B1 (fr)
CN (1) CN1204878C (fr)
AT (1) ATE172875T1 (fr)
AU (1) AU702676B2 (fr)
CA (1) CA2192110C (fr)
CZ (1) CZ356696A3 (fr)
DE (2) DE4419818C2 (fr)
DK (1) DK0765158T3 (fr)
ES (1) ES2126287T3 (fr)
FI (1) FI118952B (fr)
HU (1) HU221675B1 (fr)
IL (1) IL113930A (fr)
MY (1) MY130546A (fr)
NO (1) NO965236L (fr)
NZ (1) NZ287884A (fr)
PL (1) PL317378A1 (fr)
SK (1) SK281043B6 (fr)
WO (1) WO1995033449A1 (fr)
ZA (1) ZA954650B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU745722B2 (en) * 1996-09-07 2002-03-28 Gunther Beisel Product with extender effect
DE19745208A1 (de) * 1997-10-13 1999-04-15 Labtec Gmbh Mundfilm
DE19757298A1 (de) 1997-12-22 1999-06-24 Basf Ag Verfahren zur Herstellung von Polymerpulvern
DE19822278A1 (de) * 1998-05-18 1999-12-02 Lohmann Therapie Syst Lts Vorrichtung zur kontrollierten Freisetzung von Wirkstoff im Gastrointestinaltrakt mit verzögerter Pyloruspassage
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
FR2840221B1 (fr) * 2002-06-04 2006-01-13 Backert Marie Elisabeth Cuine Film polymerique contenant des "actifs" destines a etre liberes dans un liquide
DE102007026037A1 (de) 2007-06-04 2008-12-11 Lts Lohmann Therapie-Systeme Ag Gastroretentives System mit Alginat-Körper
DE102011006844A1 (de) 2011-04-06 2012-10-11 Siemens Aktiengesellschaft Elektrische Maschine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH624846A5 (en) * 1975-12-15 1981-08-31 Hoffmann La Roche Solid pharmaceutical unit dose form and process and apparatus for producing it
DE2746414A1 (de) * 1977-10-15 1979-04-26 Gerlach Eduard Chem Fab Mittel zum dosieren von stoffen und verfahren zu seiner herstellung
CA1273872A (fr) * 1985-05-10 1990-09-11 Larry J. Caldwell Dispositif liberant un medicament qui peut etre retenu dans l'estomac pendant une periode determinee
ES2019275B3 (es) * 1985-10-09 1991-06-16 Desitin Arzneimittel Gmbh Metodo para la produccion de una forma de administracion y de dosificacion para farmacos reactivos u otros principios activos.
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
JPH03163011A (ja) * 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd 胃内滞留デバイス
GB9203474D0 (en) * 1992-02-19 1992-04-08 Smithkline Beecham Plc Novel composition

Also Published As

Publication number Publication date
ZA954650B (en) 1996-01-26
SK281043B6 (sk) 2000-11-07
NO965236D0 (no) 1996-12-06
DK0765158T3 (da) 1999-07-19
JP3801200B2 (ja) 2006-07-26
KR100499898B1 (ko) 2005-09-05
DE59504159D1 (de) 1998-12-10
CN1149826A (zh) 1997-05-14
ES2126287T3 (es) 1999-03-16
AU2674395A (en) 1996-01-04
MX9606146A (es) 1998-06-30
NZ287884A (en) 1997-10-24
CA2192110A1 (fr) 1995-12-14
WO1995033449A1 (fr) 1995-12-14
CN1204878C (zh) 2005-06-08
FI964885A0 (fi) 1996-12-05
DE4419818C2 (de) 1998-10-22
SK157396A3 (en) 1997-09-10
MY130546A (en) 2007-06-29
EP0765158B1 (fr) 1998-11-04
FI118952B (fi) 2008-05-30
IL113930A0 (en) 1995-08-31
IL113930A (en) 1999-10-28
FI964885L (fi) 1996-12-05
DE4419818A1 (de) 1995-12-14
CZ356696A3 (en) 1997-03-12
ATE172875T1 (de) 1998-11-15
HU221675B1 (hu) 2002-12-28
JPH10500974A (ja) 1998-01-27
EP0765158A1 (fr) 1997-04-02
HUT75862A (en) 1997-05-28
PL317378A1 (en) 1997-04-01
CA2192110C (fr) 2006-05-02
KR970703134A (ko) 1997-07-03
AU702676B2 (en) 1999-03-04
HU9603326D0 (en) 1997-01-28

Similar Documents

Publication Publication Date Title
DK1037634T3 (da) Oral administrationsform som omfatter en protonpumpeinhibitor (fx pantoprazo)
ES2173142T3 (es) Dispositivo y procedimiento para la captura y recuperacion de celulas.
ATE75936T1 (de) Zusammensetzungen mit verzoegerten wirkstoffabgaben.
ATE164769T1 (de) Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen
NO893450L (no) Anvendelse av asymmetriske membraner i leveringsinnretninger.
NO912470L (no) Fremgangsmaate til fremstilling av et komposittlag paa et underlag i et apparat som inneholder elektrolytt i fast tilstand.
FI930509A0 (fi) Anvaendning av graensytpolymeriserade membraner i doseringsanordningar
DE3689150D1 (de) Druckablass-, quell- und trocknungsvorrichtung.
NO965236L (no) Aktiv substans-bærer for kontrollert frigjöring av aktiv substans i magetarmkanalen med utsatt passering gjennom pylorus
DK0951236T3 (da) Epikutant prøveplaster
AU7078787A (en) Crystal on sub-strate
DE59706576D1 (de) Orale zubereitung, enthaltend in einer in wässrigem medium quellbaren matrix wenigstens einen pharmazeutischen wirkstoff
TR200401307T4 (tr) Alfa - (2-4-Disulfofenil) N-Ter-Bütilniron ve bunların farmasötik olarak kabul edilebilen tuzları için proses
JPS5742619A (en) Adhesive tape pharmaceutical
JPS526385A (en) Release treating agent
JPS527883A (en) Agents with peeling property
SE9900772L (sv) Sätt och anordning för omslutande applicering av ett överdrag på en tablett, kapsel, piller eller liknande
ES1004557U (es) Dispositivo ambientador perfeccionado
JPS52146566A (en) Testing of semiconductor devices
EP0305194A3 (fr) Composition vétérinaire
JPS51119230A (en) Light sensitive material electronic photograph
JPS5328164A (en) Maleimide derivatives
JPS52136994A (en) Adjuvant active sobstance
JPS5274627A (en) Adhering method
NO885069D0 (no) Oral komposisjon som inneholder partikler omfattende et aktivt stoff.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application